the BRAF-driven MAPK pathway can upregulate TERT promoter activity (46), while TERT cooperates with mutant BRAF to drive tumor dedifferentiation and progression through mechanisms such as the modulation of ribosomal biogenesis (47). This evidence concerns the gene BRAF and neoplasm.